|
Written by Graham Ruecroft
|
|
Thursday, 11 June 2009 08:20 |
Prosonix provide cGMP & ATEX sonocrystallization Prosonitron™ ultrasonic process and reactor technology. They are aligned with emergent FDA “QbD” and “Design for Intent” philosophy. Our proprietary systems are of modular design for optimum flexibility and are an easy retro-fit to existing equipment. They are proven across scale in API production and can be seen as sustainable green technology.
|
|
Last Updated on Tuesday, 19 January 2010 19:38 |